From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching
Year: 2025
Type: article
Study design: Observational Study
Source: Tumori Journal
Authors: Mariangela Gaudio, Anna Floreani, Greta Schivardi, Domiziana Alaimo, Vera Basilico, Isabella Lorenzetti, Cristina Crepaldi, Benedetta Tinterri, Antonella Panzardi, Daniela Strada, Giuseppe Saltalamacchia, Flavia Jacobs, Chiara Benvenuti, Riccardo Gerosa, Jacopo Canzian, Giovambattista Rodà, Nicla La Verde, Rebecca Pedersini, Fabio Conforti, Gianpiero Rizzo, Rosalba Torrisi, Armando Santoro, Paolo Angelo Cortesi, Rita De Sanctis, Alberto Zambelli
Institutions: Humanitas University, IRCCS Humanitas Research Hospital, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Pavia, Policlinico San Matteo Fondazione, Humanitas Mater Domini, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Humanitas Gavazzeni, IRCCS Istituto Auxologico Italiano, University of Milano-Bicocca, Ospedale Papa Giovanni XXIII
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417311688